RTQA: Sensitivity Assessment System to Improve Quality in Radiation Oncology Treatment (SEAFARER)

The SEAFARER project enables clinical radiation therapy departments to assess the performance of their Patient Specific Quality Assurance (PSQA) process.

PSQA, alongside other quality assurance measures, plays an important role in delivering safe radiation therapy. PSQA tends to be resource intensive, and it has been shown to not always identify problems with treatment plans (Kry et al 2014).

Through simulation of realistic and clinically relevant treatment delivery errors, the SEAFARER project allows departments to test the sensitivity of their PSQA process. Following a successful international pilot for a stereotactic spine case (Lehmann et al 2022) the project is now being upgraded and expanded to other treatment sites.

To register your interest, complete the expression of interest survey.

Primary Sponsor

University of Newcastle

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG) & National Physical Laboratory, UK (NPL)

Trial Chairperson

Prof Peter Greer, Calvary Mater Newcastle, NSW, Australia

Prof Joerg Lehmann, Calvary Mater Newcastle, NSW, Australia

Trial Contact

seafarer@trog.com.au

Clinical Trial Registration

Related Post

Geoff Zipper - aka Swamp - on the Kokoda Trail
26 June, 2025

Cancer Survivor to Take on Fifth Kokoda trek to Support TROG

LATEST NEWS: 26 June 2025 He may be 76

24 June, 2025

TROG 2024 Annual Research Report highlights a year of achievements

LATEST NEWS: 24 JUNE 2025 The latest annual report